Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

January 16, 2021 by Alan Khadavi

Singulair psychiatric side effects; a large study

Much has been written about the potential of Singulair psychiatric side effects, with conflicting results. Singulair (montelukast) is a leukotriene-modifying agent approved for the treatment of  asthma, exercise induced bronchospasm, perennial allergic rhinitis and seasonal allergic rhinitis. It is approved for children as young as 6 months of age depending on the condition.

In 2008/09, the FDA updated the “Warnings and Precautions” of Singulair to include agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, dream abnormalities, hallucinations, insomnia, irritability, restlessness, suicidal thinking and behavior and tremor.

Since the labeling changes, there have conflicting results regarding the risks of Singulair psychiatric side effects.  A recent study published in The Journal of Allergy and Clinical Immunology: In Practice, January 2021, title “Risk of Psychiatric Adverse Events Among Montelukast Users” sought to determine whether there was an association between the two. Specifically they tried to determine whether there was an increased risk of depressive disorders, self-harm and completed suicides compared to those on Singulair vs. inhaled corticosteroid use.

The study did not find any associations between Singulair use and inpatient depressive disorder or self-harm, compared with inhaled steroid use, either overall or across subgroups of age, sex or calendar time.

The data analyzed took over a 15 year period and involved 457,377 patients, exposed to either Singulair or an inhaled steroid for asthma. Psychiatric co-morbodity was common amongst patients, most psychiatric events that did occur were in patients having a past psychiatric history.

As with all new medications, patients and doctors should closely monitor for any potential side effects. There were psychiatric side effects in both treatment groups (Singulair vs. Inhaled Steroids), but the study did not show any significant increased risk compared to one another.

A limitation of the study only compared Singulair vs. inhaled steroids, it did not compare them to untreated patients.

As always speak to your doctor about any concerns you have with medications, overall the risk was very low of singulair psychiatric side effects.

FDA advises against Singulair going OTC

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis

Filed Under: Blog, Headlines

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

September 22, 2023

How to treat Eosinophilic Esophagitis (EoE)

eosinophilic esophagitis treatment

September 14, 2023

Barley Allergy: Diagnosis and Management

barley allergy

September 11, 2023

Can the Covid Vaccine cause Hives?

covid vaccine and hives

August 30, 2023

Hops Allergy: Etiology, Presentation & Management

hops allergy

August 29, 2023

Dupixent for COPD, a new indication

dupixent for copd

August 10, 2023

Is Singulair Safe to Use? A study of Montelukast

Is Singulair safe?

July 24, 2023

Why am I so Itchy? Management of Chronic Itch

chronic itch

July 19, 2023

Potato Allergy: Can I be allergic to Potatoes?

potato allergy

July 18, 2023

Blueberry Allergy, can I be allergic to it?

blueberry allergy

June 30, 2023

Coffee Allergy: Can you be allergic to it?

coffee allergy

Read More Posts...

Follow Us…

© 2023 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page